Imaging Genetic Information - Nanotechnology for Biomedical Imaging and Diagnostics - page 386

[47] Jansson mD, Lund AH. microRNA and cancer. mol Oncol 2012; 6 :590-610.
[48] Lundstrom K. micro-RNA in disease and gene therapy. curr Drug Discov Technol
2011; 8 :76-86.
[49] Wang F, Niu g, chen X, cao F. molecular imaging of microRNAs. eur J Nucl med mol I
2011; 38 :1572-1579.
[50] Darnell Je Jr. Reflections on the history of pre-mRNA processing and highlights of
current knowledge: a unified picture. RNA 2013; 19 :443-460.
[51] muller-mcNicoll m, Neugebauer Km. How cells get the message: dynamic assembly
and function of mRNA-protein complexes. Nat Rev genet 2013; 14 :275-287.
[52] Wylie Km, Weinstock gm, Storch gA. emerging view of the human virome. Transl Res
2012; 160 :283-290.
[53] Freed eF, Bleichert F, Dutca Lm, Baserga SJ. When ribosomes go bad: diseases of ribo-
some biogenesis. mol Biosyst 2010; 6 :481-493.
[54] mukherjee A, Wickstrom e, Thakur mL. Imaging oncogene expression. eur J Radiol
2009; 70 :265-273.
[55] Kummer S, Knoll A, Socher e, Bethge L, Herrmann A, Seitz O. Fluorescence imaging of
influenza H1N1 mRNA in living infected cells using single-chromophore FIT-PNA.
Angew chem Int ed engl 2011; 50 :1931-1934.
[56] Kummer S, Knoll A, Socher e, Bethge L, Herrmann A, Seitz O. PNA FIT-probes for the
dual color imaging of two viral mRNA targets in influenza H1N1 infected live cells.
Bioconjug chem 2012; 23 :2051-2060.
[57] Sun X, Fang H, Li X, Rossin R, Welch mJ, Taylor JS. microPeT imaging of mcF-7
tumors in mice via unr mRNA-targeted peptide nucleic acids. Bioconjug chem 2005; 16 :
294-305.
[58] Lendvai g, estrada S, Bergstrom m. Radiolabelled oligonucleotides for imaging of gene
expression with PeT. curr med chem 2009; 16 :4445-4461.
[59] Yamashita T, Honda m, Kaneko S. Application of serial analysis of gene expression in
cancer research. curr Pharm Biotechnol 2008; 9 :375-382.
[60] Nikitina eg, Urazova LN, Stegny VN. microRNAs and human cancer. exp Oncol
2012; 34 :2-8.
[61] Omenn gS, menon R, Zhang Y. Innovations in proteomic profiling of cancers: alternative
splice variants as a new class of cancer biomarker candidates and bridging of proteomics
with structural biology. J Proteomics 2013; 90 :28-37.
[62] Kwon Sm, cho H, choi JH, Jee BA, Jo Y, Woo Hg. Perspectives of integrative cancer
genomics in next generation sequencing era. genomics Inform 2012; 10 :69-73.
[63] Xuan, J., Yu, Y., Qing, T., guo, L., and Shi, L., Next-generation sequencing in the clinic:
promises and challenges, cancer Lett . 2013, 340 (2):284-295.
[64] gullapalli RR, Desai KV, Santana-Santos L, Kant JA, Becich mJ. Next generation
sequencing in clinical medicine: challenges and lessons for pathology and biomedical
informatics. J Pathol Inform 2012; 3 :40.
[65] Winter J, Diederichs S. microRNA biogenesis and cancer. methods mol Biol 2011;
676 :3-22.
[66] Zhang DY, Winfree e. control of DNA strand displacement kinetics using toehold
exchange. J Am chem Soc 2009; 131 :17303-17314.
[67] Rhee WJ, Santangelo PJ, Jo H, Bao g. Target accessibility and signal specificity in live-
cell detection of BmP-4 mRNA using molecular beacons. Nucleic Acids Res 2008; 36 :e30.